Yıldız, F. and Öksüzoğlu, B. (2020) “Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer”, Journal of Surgery and Medicine, 4(6), pp. 443–446. doi: 10.28982/josam.745731.